A new study has revealed that using ecstasy and similar drugs may increase the risk of valvular heart disease.
The researchers discovered an association between serotonergic activity and cardiac valvular pathology.
The findings, outlined in The British Media Journal, suggested that 3,4-Methylenedioxymethamphetamine, aka MDMA could potentially increase the odds of valvular heart disease.
The study also found that the same affect applies for any medications that increase serotonin or dopamine levels.
“The link between certain medications and valvular pathologies has been well established in the literature. Evidence from the basic and translational sciences has indicated that these medications may exert their effect through serotonergic pathways,” University of Ottawa Heart Institute's Jacqueline H. Fortier, MSc and her colleagues concluded.
“There was a consistent, significant relationship between certain medications and heart valve disease, including serotonergic medications and dopaminergic medications.”